Related Experiment Videos
Endotoxin requirements for alveolar macrophage stimulation
R V Maier1, G B Hahnel, T H Pohlman
1Department of Surgery, Harborview Medical Center, Seattle, WA 98104.
The Journal of Trauma
|December 1, 1990
Summary
Sepsis-induced acute pulmonary failure involves macrophages releasing inflammatory mediators. Blocking endotoxin stimulation of macrophages with bacterial components may prevent acute respiratory distress syndrome (ARDS).
Area of Science:
- Immunology
- Pulmonary Medicine
- Critical Care Medicine
Background:
- Acute pulmonary failure, or ARDS, is a significant complication in severely injured patients.
- Sepsis syndrome, a systemic inflammatory response, is a major risk factor for ARDS.
- Tissue-fixed macrophages, like alveolar macrophages, play a central role in mediating sepsis-induced inflammation and organ injury.
Purpose of the Study:
- To investigate the role of endotoxins (LPS) in stimulating macrophages.
- To explore potential therapeutic strategies for modulating macrophage responses in sepsis.
- To understand the molecular interactions between LPS and macrophages to prevent ARDS.
Main Methods:
- Utilized in vitro studies with alveolar macrophages.
- Administered varying doses of LPS from E. coli 0111:B4 to assess macrophage stimulation.
- Tested LPS from Bacteroides fragilis and Lipid X for their ability to stimulate or block macrophage activation.
Main Results:
- E. coli LPS dose-dependently stimulated high levels of procoagulant activity (PCA) and tumor necrosis factor (TNF) in alveolar macrophages.
- LPS from Bacteroides fragilis and Lipid X did not stimulate macrophages in vitro.
- Both B. fragilis LPS and Lipid X effectively competed with E. coli LPS, blocking macrophage stimulation.
Conclusions:
- Macrophage-derived mediators like PCA and TNF contribute to sepsis pathophysiology and ARDS.
- Endotoxins are key stimuli for macrophage activation.
- Bacterial components like B. fragilis LPS and Lipid X show potential as inhibitors of LPS-induced macrophage activation, offering a novel therapeutic avenue for ARDS prevention.